European heart journal
-
European heart journal · May 1994
Case ReportsAcute myocardial infarction following blunt chest trauma.
A 32-year-old male riding a motorcycle was involved in an accident resulting in blunt torso trauma. He had fractures of the skull, first right rib, and left femoral bone. ⋯ Echocardiogram showed depressed left ventricular function as well as hypokinesis over septal and apical areas. His recovery was smooth.
-
European heart journal · Feb 1994
Paediatric cardiology in Europe--medical/scientific statement of the Association of European Paediatric Cardiologists. Definition of profession and training requirements.
The treatment of growing and developing individuals with heart and circulation diseases demands expertise and organization. Due to the unification of Europe, international exchange of doctors can take place. The Association of European Paediatric Cardiologists had laid down professional and training requirements to harmonize the field of patient care, training and training institutes all over Europe.
-
European heart journal · Jan 1994
Editorial Review Comparative StudyGUSTO (Global Utilization of Streptokinase and Tissue plasminogen activator in Occluded arteries): logic wins at last.
-
European heart journal · Oct 1993
Review Comparative StudyEffects of beta-blockers and calcium channel blockers in acute myocardial infarction.
beta-blockers and calcium channel blockers have been evaluated extensively during the acute phase and following myocardial infarction. beta-blockers, when administered early and intravenously, reduce early mortality, reinfarction and cardiac arrests by about 16%. The reduction in mortality is likely to be due to multiple mechanisms including reductions in cardiac rupture, reinfarction and ventricular fibrillation. Recent data also suggest a reduction in intracranial haemorrhage when administered in conjunction with thrombolytic therapy. ⋯ On the other hand, agents that reduce heart rate (verapamil and diltiazem) appear to have a neutral effect on mortality but may reduce reinfarction rates. The benefits of beta-blockers appear to be consistent in most subgroups of patients examined, whereas the adverse effects of calcium channel blockers are most marked in those with large infarcts or heart failure. In conclusion, beta-blockers are preferable to calcium channel blockers in the acute phase and long-term after myocardial infarction.